Our Amazing
Premier Sponsors
GT Medical Technologies was founded by a dedicated team of brain tumor specialists to address unmet needs in brain tumor treatment. The company is committed to improving the lives of patients with brain tumors through innovative solutions that elevate the standard of care.
GammaTile is an FDA-cleared, bioabsorbable collagen implant embedded with radiation seeds, designed for patients with operable brain tumors. By delivering radiation directly from within—placed into the surgical cavity at the time of tumor removal—GammaTile provides immediate, localized treatment. This approach targets remaining cancer cells when they are at their lowest levels to help prevent regrowth, while minimizing radiation exposure to healthy brain tissue.
Since its full market launch in the United States in March 2020, GammaTile has been adopted by more than 100 leading centers, underscoring its growing acceptance in both academic and community healthcare settings. Visit gammatile.com to learn more or follow @GammaTile on Twitter, Facebook and LinkedIn.
With our lead investigational asset, CT-179, we have successfully developed a first-in-class, highly brain-penetrant small molecule designed to physically disrupt OLIG2 dimerization, effectively neutralizing its ability to fuel tumor growth and hide the tumor from the immune system.
Episode Sponsors
Highmark Blue Cross Blue Shield of WNY
Care that fits your life! Highmark Blue Cross Blue Shield of Western New York has built a legacy around empowering our communities and helping you be your very best you. They offer health plans that provide reliable coverage to Western New Yorkers and by supporting the organizations and individuals who work hard every day to keep our communities healthy. Learn more at https://www.bcbswny.com/
Alpheusmedical
Alpheus Medical is a private, clinical-stage biotechnology company developing a novel therapeutic approach based on Porphyrin Metabolite Activation (PoMA). This drug-centered strategy leverages a molecule that preferentially accumulates in tumor cells, followed by activation using low-intensity ultrasound to enable localized pharmacologic effect. This non-invasive approach is designed to activate the molecule directly within tumor cells while minimizing systemic therapy exposure, potentially addressing the diffuse nature of the disease.
Tactical Therapeutics
Tactical Therapeutics, Inc (“TTI”) a Delaware Corporation formed in 2005 in New York, has developed a patented lead clinical candidate Carboxyamidotriazole (CTO) to circumvent resistance and immunosuppression in the treatment of in several solid cancers and glioblastoma in adults and children. The story of Tactical Therapeutics is one of the most amazing ongoing narratives in the life sciences today.
TTI is privately funded; its CEO and Founder being Rashida Karmali, and uses a Virtual Business Model by outsourcing most of the drug development activities to top-tier contractors and service providers.
Interested in being a sponsor of Game On Glio?
Fill out this form and we will respond shortly.